Jacek Cieslak - FDA Investigator Report

Designation: CHEMIST

Duty Station: Silver Spring MD 20993-0002

Organizations: DHHS FDA CDER OMPT CDER OPQ OBP DBRRIV

Overview Statistics

12
Total Inspections
10
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 12 days
Shortest Inspection: 2 days
Average Length: 8.0 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Jacek Cieslak's Recent Inspections

DateCompanyCityCountryFEI Number483
2024-01-30AbbVie Bioresearch CenterWorcesterUnited States3003684386
2023-09-01Samsung Biologics Co., Ltd.YeonsuKorea (the Republic of)3010479596
2023-01-24Alexion Pharma International Operations Unlimited Co.Dublin 15Ireland3012889718
2022-06-10SEAGEN INC.BothellUnited States3002781621
2022-03-25Formycon AgPlaneggGermany3010190542
2022-03-22Polpharma Biologics S.AGdanskPoland3013195136
2021-08-30Kyowa Hakko Kirin Co., Ltd.TakasakiJapan3007588904
2021-08-30Kyowa Hakko Kirin Co., Ltd.TakasakiJapan3007588904
2021-08-23Chugai Pharma Manufacturing Co. Ltd. (CPMC)KitaJapan3004109596
2021-04-21FujiFilm Diosynth Biotechnologies U.S.A., Inc.Research Triangle ParkUnited States3000718852

Sign Up to get the complete report.

Download 483s and EIRs for Jacek Cieslak

Jacek Cieslak - Co-Inspectors

Jacek Cieslak's Active Locations

  • Japan
  • United States
  • Korea (the Republic of)
  • Poland
  • Ireland
  • Germany
  • Austria

Jacek Cieslak's Year-wise Inspection Count

  • 2018:1 inspections
  • 2019:1 inspections
  • 2021:4 inspections
  • 2022:3 inspections
  • 2023:2 inspections
  • 2024:1 inspections
Last Updated: 2025-05-14 06:11:22